Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Guidelines aim to improve London outcomes for skin cancer  

  • Comment

New guidelines have been launched to ensure consistently high standards of care for patients with skin cancer across south and west London.

The guidance has been developed by the London Cancer Alliance’s skin pathway group, which worked collaboratively with clinicians across south and west London.

The alliance was established in 2011 as the integrated cancer system across west and south London. It works in partnership with 16 NHS trusts, primary care, the voluntary and third sector and patients.

The LCA Skin Cancer Guidelines have been produced for all healthcare professionals involved in the diagnosis and treatment of skin cancers, who work in the organisations covered by the alliance.

The guidelines recommend that all health professionals, whether in a community or hospital setting, who treat patients with skin cancer should be a member of a multidisciplinary team.

There should be two levels of these multidisciplinary teams for the treatment of skin cancer – local and specialist.

The guidelines also make specific recommendations for the management of basal cell carcinomas and the management of higher risk and complex skin cancers.

St Georges Healthcare NHS Trust

Barry Powell

Professor Barry Powell, chair of the skin pathway group and a surgeon at St Georges Healthcare NHS Trust, said: “The LCA Skin Cancer Guidelines are vitally important to ensure all patients in south and west London experience the same high level of care and treatment, as well as setting out best practice for communication, survivorship and follow up.”

The LCA has also produced clinical guidelines for lung cancer, breast cancer, acute oncology and brain and central nervous system cancers.

Head and neck/thyroid cancer and gynaecology cancer guidelines will be published shortly.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.